Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study

BACKGROUND: Therapeutic modulation of TREM2-dependent microglial function might provide an additional strategy to slow the progression of Alzheimer's disease. Although studies in animal models suggest that TREM2 is protective against Alzheimer's pathology, its effect on tau pathology and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Morenas-Rodríguez, Estrella, Li, Yan, Nuscher, Brigitte, Franzmeier, Nicolai, Xiong, Chengjie, Suárez-Calvet, Marc, Fagan, Anne M, Schultz, Stephanie, Gordon, Brian A, Benzinger, Tammie L S, Hassenstab, Jason, McDade, Eric, Feederle, Regina, Karch, Celeste M, Schlepckow, Kai, Morris, John C, Kleinberger, Gernot, Nellgard, Bengt, Vöglein, Jonathan, Blennow, Kaj, Zetterberg, Henrik, Ewers, Michael, Jucker, Mathias, Levin, Johannes, Bateman, Randall J, Haass, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926925/
https://www.ncbi.nlm.nih.gov/pubmed/35305339
http://dx.doi.org/10.1016/S1474-4422(22)00027-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926925/
https://www.ncbi.nlm.nih.gov/pubmed/35305339
http://dx.doi.org/10.1016/S1474-4422(22)00027-8

Ejemplares similares